Systematic Review of Therapy Used in Higher-Risk (HR) Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
2017
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI